CD8+ T effector and immune checkpoint signatures predict prognosis and responsiveness to immunotherapy in bladder cancer-Reference-Cited by-同舟云学术

CD8+ T effector and immune checkpoint signatures predict prognosis and responsiveness to immunotherapy in bladder cancer

Published:2021-09-22 Issue:43 Volume:40 Page:6223-6234
ISSN:0950-9232
Container-title:Oncogene
language:en
Short-container-title:Oncogene

Author:

Chen Xingyu,Xu Runshi,He Dong,Zhang Yao,Chen Haotian,Zhu Yuxing,Cheng YaXin,Liu Rui,Zhu Rongrong,Gong Lian,Xiao Mengqing,Wang Zhanwang,Deng Liping,Cao Ke^ORCID

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Genetics,Molecular Biology

Link

https://www.nature.com/articles/s41388-021-02019-6.pdf

Reference33 articles.

1. Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A. et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71:209–249. https://doi.org/10.3322/caac.21660.

2. Saginala K, Barsouk A, Aluru JS, Rawla P, Padala SA, Barsouk A. Epidemiology of bladder cancer. Med Sci (Basel). 2020;8:15. https://doi.org/10.3390/medsci8010015.

3. Sell V, Ettala O, Montoya Perez I, Jarvinen R, Pekkarinen T, Vaarala M, et al. Symptoms and diagnostic delays in bladder cancer with high risk of recurrence: results from a prospective FinnBladder 9 trial. World J Urol. 2020;38:1001–7.

4. Antoni S, Ferlay J, Soerjomataram I, Znaor A, Jemal A, Bray F. Bladder cancer incidence and mortality: a global overview and recent trends. Eur Urol. 2017;71:96–108.

5. Jimenez-Sanchez A, Cybulska P, Mager KL, Koplev S, Cast O, Couturier DL, et al. Unraveling tumor-immune heterogeneity in advanced ovarian cancer uncovers immunogenic effect of chemotherapy. Nat Genet. 2020;52:582–93.

Cited by 57 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Data-mining-based biomarker evaluation and experimental validation of SHTN1 for bladder cancer;Cancer Genetics;2024-11

2. Immune checkpoint gene signature assesses immune infiltration profiles in bladder cancer and identifies KRT23 as an immunotherapeutic target;BMC Cancer;2024-08-19

3. The deubiquitinase USP2a promotes tumor immunosuppression by stabilizing immune checkpoint B7–H4 in lung adenocarcinoma harboring EGFR-activating mutants;Cancer Letters;2024-08

4. Identification and validation of basement membrane-related genes predicting prognosis and immune infiltration associated with bladder cancer;Medicine;2024-07-19

5. Investigating the complex interplay between fibroblast activation protein α-positive cancer associated fibroblasts and the tumor microenvironment in the context of cancer immunotherapy;Frontiers in Immunology;2024-07-05